文献速递流行病学与生物统计医学教育与科研方法

随机化:随机对照试验中被遗忘的组分

Randomization: The forgotten component of the randomized clinical trial.
PubMed 文献 · Stat Med · 2018-07-25

本文回顾上世纪关于随机化的统计学文献,梳理了随机化的三条理由,其中「随机化本身为推断提供基础」这一条常被遗忘或忽视。文章描述了基于随机化的推断方法,可用于临床试验中几乎任何感兴趣的结局,并特别提及非标准临床试验情形。

要点

  • 随机化的三条理由:减少选择偏倚、平衡已知与未知混杂、为推断提供基础。
  • 第三条理由常被遗忘或忽视,导致随机化在方案和论文中沦为形式。
  • 基于随机化的推断可用于临床试验中几乎任何结局,包括非标准情形。

核心结论

  • 随机化不仅是分配机制,其本身为临床试验推断提供基础,这一理由常被遗忘或忽视。

研究设计与样本

  • 本文为文献综述,回顾上世纪关于随机化方法及其后果的统计学文章。

主要发现

  • 早期文献归纳出随机化的三条理由:减少选择偏倚、平衡混杂、为推断提供基础。
  • 第三条理由常被遗忘、忽视或未教授,随机化在方案和论文中多沦为形式。

关键数值与推荐

  • 原文引用Armitage 1954年表述:检验基于初始假设下重复抽样所有可能结果的概率枚举。

临床怎么用

  • 文章描述基于随机化的推断可用于临床试验中几乎任何感兴趣的结局。
  • 特别提及非标准临床试验情形下随机化推断的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

"…The customary test for an observed difference…is based on an enumeration of the probabilities, on the initial hypothesis that two treatments do not differ in their effects,…of all the various results which would occur if the trial were repeated indefinitely with different random samples of the same size as those actually used." -Peter Armitage ("Sequential tests in prophylactic and therapeutic trials" in Quarterly Journal of Medicine, 1954;23(91):255-274). Randomization has been the hallmark of the clinical trial since Sir Bradford Hill adopted it in the 1946 streptomycin trial. An exploration of the early literature yields three rationales, ie, (i) the incorporation of randomization provides unpredictability in treatment assignments, thereby mitigating selection bias; (ii) randomization tends to ensure similarity in the treatment groups on known and unknown confounders (at least asymptotically); and (iii) the act of randomization itself provides a basis for inference when random sampling is not conducted from a population model. Of these three, rationale (iii) is often forgotten, ignored, or left untaught. Today, randomization is a rote exercise, scarcely considered in protocols or medical journal articles. Yet, the literature of the last century is rich with statistical articles on randomization methods and their consequences, authored by some of the pioneers of the biostatistics and statistics world. In this paper, we review some of this literature and describe very simple methods to rectify some of the oversight. We describe how randomization-based inference can be used for virtually any outcome of interest in a clinical trial. Special mention is made of nonstandard clinical trials situations.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Rosenberger WF, Uschner D, Wang Y, et al. Randomization: The forgotten component of the randomized clinical trial. Stat Med. 2018. PMID: 30047159. doi:10.1002/sim.7901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。